Clinical Trial Details


Research Study Summary

Is your teen struggling with symptoms of ADHD?


Peninsula Research Associates is conducting an ADHD trial that is testing two different medications, Vyvanse™ and Concerta™, which are both FDA approved and commonly used to treat ADHD. Study participation requires approximately 8 - 10 visits over the course of about 11 – 13 weeks.

Qualified participants may receive up to $250.00 compensation for time and travel.

Study related procedures are provided at no charge, including:

  • ADHD assessment
  • Confidential study related physical exams and laboratory services
  • Study medication
  • One-on-one, private physician visits
  • Study follow-up
  • Flexible appointment hours

Patient Inclusion Criteria

  • Be male or female, aged 13-17 years.
  • Be diagnosed with ADHD or have symptoms of ADHD.

Patient Exclusion Criteria

  • History of substance abuse
  • Has taken taken part in a clinical study within the past 30 days
  • Females who are pregnant or lactating

To Learn more

CW ID: 182269
Date Last Changed: July 18, 2013

Clinical Trial Snapshot

Both Male and Female
13 to 17 Years
Overall Status
13 Weeks
Facility Type
Up to $250


Peninsula Research Associates
550 Deep Valley Drive, Suite 317
Rolling Hills Estates, CA 90274
Phone: 310-265-1623
Fax: 310-265-1753

View Map

Research Center Information:

Peninsula Research Associates

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.